Results 71 to 80 of about 604 (128)

Hematogones: The Supreme Mimicker and a Cytomorphological Confounder in Acute Lymphoblastic Leukemia. [PDF]

J Lab Physicians, 2023
Singh K, Tiwari D, Boddu R, Somasundarum V, Mishra K.   +4 more
europepmc   +1 more source

Hematogônias x linfoblastos leucêmicos: a imunofenotipagem por citometria de fluxo resolve o dilema? Hematogones x neoplastic lymphoblasts: does the immunophenotyping by flow cytometry solve the dilemma?

Revista Brasileira de Hematologia e Hemoterapia, 2006
Nydia S. Bacal
doaj   +1 more source

Impact of CD34 ⁺ Bone Marrow Cell Heterogeneity and HMOX1 Promoter Polymorphism on Neutrophil Engraftment in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation. [PDF]

Eur J Haematol
Bukowska-Strakova K, Moskwa M, Sieminska I, Zatorska-Kwiecień M, Sawa M, Wieczorek A, Pocheć A, Gozdzik J, Siedlar M, Pawinska-Wasikowska K.   +9 more
europepmc   +1 more source

X-linked SEPTIN6-related congenital neutropenia and B cell deficiency. [PDF]

J Hum Immun
Gunderman LM, Petrovic A, Lundgren I, Chisholm KM, Bohling SD, Fromm JR, Ferrannini A, Torgerson TR, Dutmer CM, Hsieh EWY, Mohamad SF, Williams DA, Allenspach EJ.   +12 more
europepmc   +1 more source

Measurable Residual Disease Assessment in B-Lymphoblastic Leukemia Using 5- and 10-Color Flow Cytometry: An Institutional Experience. [PDF]

Cureus
Narayanan AV, Murugesan M, Nair C, Nayanar SK, Tk J, Kg G.   +5 more
europepmc   +1 more source

Practical diagnostic approach to assess myeloid and precursor cell neoplasms on trephine bone marrow biopsies: reflection of middle European reality. [PDF]

J Hematop
Menter T, Tzankov A.
europepmc   +1 more source

Artificial intelligence accelerates the interpretation of measurable residual B lymphoblastic leukemia by flow cytometry. [PDF]

Blood Adv
Seheult JN, Otteson GE, Timm MM, Weybright MJ, Shi M, Olteanu H, Jevremovic D, Chen C, Chiu A, Horna P.   +9 more
europepmc   +1 more source

CD9: Differential expression of normal bone marrow cellular components and leukemic myeloid blasts. [PDF]

Am J Clin Pathol
Jasim A, Lee W, Ma H, Quirk E, Song J, Hwee S, Hughes J, Tizro P, Soma L.   +8 more
europepmc   +1 more source

Maintenance after CAR T? Are we there yet? Reducing the risk of relapse after loss of anti-CD19 CAR T-cell persistence in ALL. [PDF]

Hematology Am Soc Hematol Educ Program
Gabelli M, Ghorashian S.
europepmc   +1 more source

The Flow Cytometric Evaluation of B- and T-Lymphoblastic Leukemia/Lymphoma. [PDF]

Cancers (Basel)
Dorfman DM.
europepmc   +1 more source